Come up with a name for your new list and we'll add to it:
Corbus Pharmaceuticals raised a round of funding on April 23, 2014. Investors include
Ascent Biomedical Ventures.
Corbus Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat life threatening ("orphan") inflammatory-fibrotic d…